Immunoinformatics may lead to a reappraisal of the nature of B cell epitopes and of the feasibility of synthetic peptide vaccines

Journal of Molecular Recognition

Volumn 19, Issue 3, 2006, Pages 183-187

  Van Regenmortel, Marc H V ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; PEPTIDE FRAGMENT; RECOMBINANT VACCINE;

ANIMAL; ANTIBODY PRODUCTION; B LYMPHOCYTE; BIOLOGY; EDITORIAL; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOUSE;

ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; COMPUTATIONAL BIOLOGY; EPITOPES, B-LYMPHOCYTE; MICE; PEPTIDE FRAGMENTS; VACCINES, SYNTHETIC;

EID: 33745047144     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.768     Document Type: Editorial

References (58)

1. Atassi MZ, Smith JA. 1978. A proposal for the nomenclature of antigenic sites in peptides and proteins. Immunochemistry 15: 609-610.
2. Van Regenmortel MHV. 1999. Molecular dissection of protein antigens and the prediction of epitopes. In Synthetic Peptides as Antigens, Van Regenmortel MHV, Muller S (eds). Elsevier. Amsterdam; 1-78.
3. Laver WG, Air GM, Webster RG, Smith-Gill SJ. 1990. Epitopes on protein antigens: misconceptions and realities. Cell 61: 553-556.
4. Green N, Alexander H, Olson A, et al. 1982. Immunogenic structure of the influenza virus hemagglutinin. Cell 28: 477-487.
5. Lerner RA. 1984. Antibodies of predetermined specificity in biology and medicine. Adv. Immunol. 36: 1-44.
6. Kennel SJ. 1982. Binding of monoclonal antibody to protein antigen in fluid phase or bound to solid supports. J Immunol Meth 55: 1-12.
7. Darst SA, Robertson CR, Berzofsky J. 1988. Adsorption of the protein antigen myoglobin affects the binding of conformation-specific monoclonal antibodies. Biophys. J. 53: 533-539.
8. Van Regenmortel MHV. 1989. Structural and functional approaches to the study of protein antigenicity. Immunol. Today 10: 266-272.
9. Van Regenmortel MHV. 1995. Transcending the structuralist paradigm in immunology: affinity and biological activity rather than purely structural considerations should guide the design of synthetic peptide epitopes. Biomed. Pept. Prof. & Nucl Acids 1: 109-116.
10. Greenspan NS, Di Cera E. 1999. Defining epitopes: it's not as easy as it seems. Nat. Biotech. 17: 936-937.
11. Wilson IA, Stanfield RL. 1994. Antigen - antibody interactions: new structures and new conformational changes. Curr. Opin. Struct. Biol. 4: 857-867.
12. Roberts VA, Getzoff ED, Tainer JA. 1992. Structural basis of antigenic cross-reactivity. In Structure of Antigens (Vol 2), Van Regenmortel MHV (ed.). CRC Press: Boca Raton; 31-53.
13. Churchill MEA, Stura EA, Pinella C, et al. 1991. Crystal structures of a peptide complex of anti-influenza peptide antibody Fab 26/9J. Mol Biol 241: 534-556.
14. Leinikki P, Lehtinen M, Hyöty H, Parkkonen P, Kantanen ML, Hakulinen J. 1993. Synthetic peptides as diagnostic tools in virology. Adv Virus Res 42: 149-186.
15. Walter G. 1986. Production and use of antibodies against synthetic peptides. J. Immun. Meth. 88: 149-161.
16. Nicholson BH. 1994. Synthetic Vaccines. Blackwell Scientific: Oxford.
17. Van Regenmortel MHV. 1999. Synthetic peptides as vaccines. In Synthetic Peptides as Antigens, Van Regenmortel MHV, Muller S (eds). Elsevier: Amsterdam; 281-317.
18. Friede M, Muller S, Briand JP, Schuber F, Van Regenmortel MHV. 1993. Generation of antibodies cross-reactive with proteins by peptide immunization. In Immunotechnology, Gosling JP, Reen DJ (eds). Portland Press: London; 1-11.
19. Pellequer JL, Westhof E, Van Regenmortel MHV. 1993. Correlation between the location of antigenic sites and the prediction of turns in proteins. Immunol. Lett. 36: 83-100.
20. Pellequer JL, Westhof E, Van Regenmortel MHV. 1994. Epitope predictions from the primary structure of proteins. In Peptide Antigens: A Practical Approach, Wisdom GB (ed.). JRL Press: Oxford; 7-25.
21. Getzoff ED, Tainer JA, Lerner RA, Geysen HM. 1988. The chemistry and mechanism of antibody binding to protein antigens. Adv. Immunol. 43: 1-98.
22. Hopp TP. 1993. Retrospective: 12 years of antigenic determinant prediction and more. Pept. Res. 6: 183-190.
23. Van Regenmortel MHV, Pellequer JL. 1994. Predicting antigenic determinants in proteins: looking for unidimensional solutions to a three-dimensional problem? Pept. Res. 7: 224-228.
24. Pellequer JL, Westhof E. 1993. PREDITOP: a program for antigenicity prediction. J. Mol. Graphics. 11: 204-210.
25. Alix AJP. 2000. Predictive estimation of protein linear epitopes by using the program PEOPLE. Vaccine 18: 311-314.
26. Odorico M, Pellequer JL. 2003. BEPITOPE: predicting the location of continuous epitopes and patterns in proteins. J. Mol. Recogn. 16: 20-22.
27. Blythe MJ, Flower DR. 2005. Benchmarking B cell epitope prediction: underperformance of existing methods. Protein Science 14: 246-248.
28. Toseland CP, Clayton DJ, McSparron H, et al. 2005. AntiJen: a quantitative immunology database integrating functional, thermodynamic, kinetic, biophysical and cellular data. BMC Immunome Research 1: 4.
29. Schönbach C, Koh JLY, Flower DR, Brusic V. 2005. An update of the functional molecular immunology (FIMM) database. Appl. Bioinformatics 4: 25-31.
30. Saha S, Bhasin M, Raghava GP. 2005. Bcipep: a database of B-cell epitopes. BMC Genomics 6: 79.
31. Sathiamurthy M, Peters B, Bui HH, et al. 2005. An ontology for immune epitopes: application to the design of a broad scope database of immune reactivities. Immunome Res. 1: 2. DOI:10.1186/1745-7580-1-2
32. Schlessinger A, Ofran Y, Yachdav G, Rost B. 2006. Epitome: database of structure-inferred antigenic epitopes. Nucleic Acids Res 34: Database Issue, D777-D780.
33. Trifilieff F, Dubs MC, Van Regenmortel MHV. 1991. Antigenic cross-reactive potential of synthetic peptides immobilized on polyethylene rods. Mol. Immunol. 28: 889-896.
34. Van Regenmortel MHV. 1998. Mimotopes, continuous paratopes and hydropathic complementarity: novel approximations in the description of immunological specificity. J. Disp. Science & Technol. 19: 1199-1219.
35. Heap CJ, Wang Y, Pinheiro TJT, et al. 2005. Analysis of a 17 - amino acid residue virus-neutralizing microantibody. J. Gen. Virol. 86: 1791-1800.
36. Levi M, Sällberg M, Ruden U, et al. 1993. A complementary- determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro. Proc. Natl. Acad. Sci. USA 90: 4374-4378.
37. Laune D, Molina F, Ferrieres G, et al. 1997. Systematic exploration of the antigen binding activity of synthetic peptides isolated from the variable regions of immunoglobulins. J. Biol. Chem. 272: 30937-30944.
38. Jemmerson R. 1987. Antigenicity and native structure of globular proteins: low frequency of peptide reactive antibodies. Proc. Natl. Acad. Sci. USA 84: 9180-9184.
39. Leder L, Wendt H, Schwab C, et al. 1994. Genuine and apparent cross-reaction of polyclonal antibodies to proteins and peptides. Eur. J. Biochem 219: 73-81.
40. Spangler BD. 1991. Binding to native proteins by antipeptide monoclonal antibodies. J. Immunol. 146: 1591-1595.
41. Van Regenmortel MHV. 1994. Use of biosensors to characterize recombinant proteins. Dev. Biol. Stand. 83: 143-151.
42. Van Regenmortel MHV. 1999. Peptide immunoassays. In Synthetic Peptides as Antigens, Van Regenmortel MHV, Muller S (eds). Elsevier: Amsterdam; 179-214.
43. Van Regenmortel MHV, Choulier L. 2001. Recognition of peptides by antibodies and investigations of affinity using biosensor technology. Combin. Chem. High Throughput Screen 4: 385-395.
44. Batori V, Friis EP, Nielsen H, Roggen EL. 2006. An in silico method using an epitope motif database for predicting the location of antigenic determinants on proteins in a structural context. J. Mol. Recognit. 19: 21-29.
45. Söllner J, Mayer B. 2006. Machine learning approaches for prediction of linear B cell epitopes on proteins. J. Mol. Recognit. 19; 200-208.
46. Söllner J. 2006. Selection and combination of machine learning classifiers for prediction of linear B cell epitopes on proteins. J. Mol. Recognit. 19: 209-214.
47. Flower DR, Doytchinova IA. 2002. Immunoinformatics and the prediction of immunogenicity. Appl Bioinformatics 1: 167-176.
48. De Groot AS, Martin W. 2003. From immunome to vaccine: epitope mapping and vaccine design tools. In Immunoinformatics; Novartis Foundation Symposium 254. John Wiley & Sons: Chichester, UK; 57-76.
49. Van Regenmortel MHV. 2001. Antigenicity and immunogenicity of synthetic peptides. Biologicals 29: 209-213.
50. Berzofsky JA. 1985. Intrinsic and extrinsic factors in protein antigenic structure. Science 229: 932-940.
51. Van Regenmortel MHV. 1999. Molecular design versus empirical discovery in peptide-based vaccines. Coming to terms with fuzzy recognition sites and ill-defined structure-function relationships in immunology. Vaccine 18: 216-221.
52. Van Regenmortel MHV. 2001. Pitfalls of reductionism in the design of peptide-based vaccines. Vaccine 19: 2369-2374.
53. Langeveld JPL, Casal JI, Osterhaus ADME, et al. 1994. First peptide vaccine providing protection against viral infection in the target animal: studies of a canine parovirus in dogs. J. Virol. 68: 4506-4513.
54. Fischer D, Rood D, Barrette RW, et al. 2003. Intranasal immunization of guinea pigs with an immunodominant foot-and-mouth disease virus peptide conjugate induces mucosal and humoral antibodies and protection against challenge. J. of Virol. 77: 7486-7491.
55. Uversky VN, Oldfield CJ, Dunker AK. 2005. Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling. J. Mol. Recognit. 18: 343-384.
56. Ho J, Uger RA, Zwick MB, et al. 2005. Conformational constraints imposed on a pan-neutralizing HIV-1 antibody epitope result in increased antigenicity but not neutralizing response. Vaccine 23: 1559-1573.
57. Van Regenmortel MHV, 2004. Reductionism and complexity in molecular biology. EMBO Reports 5: 1016-1020.
58. Nargi F, Kramer E, Mezencio J, et al. 1999. Protection of swine from foot-and-mouth disease with one dose of an all-D retro peptide. Vaccine 17: 2888-2893.